Filing metadata

Accession number
0001641172-25-014569
Form type
Form 4
Filer
Aspire Biopharma Holdings, Inc.
CIK
CIK 1847345
Filed
Jun 10, 2025
Reporting period
Jun 04, 2025
Description
Insider transaction

Explore SEC Filings Hub